Chronogen, Zambon Group S.p.A. deal

Chronogen and Zambon's subsidiary Inpharzam Ricerche (Taverne, Switzerland) partnered to identify small molecules to treat cardiovascular and metabolic diseases caused by oxidative damage and lipid di...